[1]
2020. Baseline Characteristics of Atopic Dermatitis (AD) and AD Treatments in a Cohort of Adult AD Patients Initiating Dupilumab in a Real-World Registry (PROSE). SKIN The Journal of Cutaneous Medicine. 4, 6 (Oct. 2020), s106. DOI:https://doi.org/10.25251/skin.4.supp.106.